$1.30 -0.03 (-2.26%)
11/25/2009 3:59 PM

Dynavax Technologies Corp (DVAX)

CAPS Rating: 5 out of 5

A biopharmaceutical company that discovers and develops Toll-like Receptor 9 and agonist-based products to treat and prevent infectious diseases, allergies, cancer and chronic inflammatory.

Results 1 - 16 of 16

Recs

0
Member Avatar wontfindaname (< 20) Submitted: 3/18/2008 5:49:41 PM : Outperform Start Price: $2.46 DVAX Score: -29.04

Expect the huge gap to get filled over the next few days and a slow rise back to 6 over the next couple of months.

Recs

0
Member Avatar uberpaige (< 20) Submitted: 2/26/2007 2:12:23 PM : Outperform Start Price: $5.20 DVAX Score: -56.55

another hope for quick accuracy points.

Recs

2
Member Avatar foolphighter (< 20) Submitted: 1/12/2007 2:11:42 AM : Outperform Start Price: $6.02 DVAX Score: -61.59

Small biotech has recently released promising late stage trial results for its HEPLSAV hepatitus B vaccine drug, as well as encouraging earlier stage results for its TLR9 agonist in cancer indications. The stock took a large hit Jan. 8th when its TOLAMBA allergy drug failed to show therapeutic benefit based on interim analysis, that appears to present a buying opportunity, particularly since the reason for the failure appears to be the lack of clinically significant disease in the study population. Cash of $1.50/share & no debt and the recent filing of a $100M shelf registration suggests the company is well-positioned to leverage its recent progress into further positive developments. the stock appears to offer a reasonable risk/reward after the recent sell-off.

Recs

0
Member Avatar tekrider (< 20) Submitted: 12/27/2006 11:22:09 AM : Outperform Start Price: $8.98 DVAX Score: -68.39

this company has the best TLR-9 technology and excellent recent clinical trial results on both its allergy program and hepatitis B vaccine program, both of which address large markets.

Recs

0
Member Avatar southernair (< 20) Submitted: 12/19/2006 3:50:10 PM : Outperform Start Price: $9.00 DVAX Score: -68.89

This Co. has a cure for hayfever. There's a very large demand for such a product. Buckle up your seat belts for a nice ride up.

Recs

0
Member Avatar biodetector (31.78) Submitted: 12/15/2006 12:09:51 PM : Outperform Start Price: $9.37 DVAX Score: -68.87

I was evaluating their research data regarding influenza vaccines and missed the doubling in stock price, but this may just be the start. Their patented methods widen the range of protection from immunizations. This could be HUGE if it means protection from future viral epidemics.

Recs

0
Member Avatar billblattner (72.18) Submitted: 12/12/2006 10:49:57 AM : Outperform Start Price: $9.90 DVAX Score: -70.33

This sock is moving up, and its on news that has nothing to do with the alergy break thu, that will propel this company to the outer limits. All of my family has an alergy problem and are waiting for this pill or shot.

Recs

0
Member Avatar hawkider (57.69) Submitted: 12/7/2006 4:04:53 PM : Underperform Start Price: $9.52 DVAX Score: +70.13

House of cards

Recs

1
Member Avatar halmcneely (27.97) Submitted: 11/24/2006 5:17:17 PM : Outperform Start Price: $7.70 DVAX Score: -67.44

Stong findings for a much-needed vaccine; results exceed early prognosis. Large populations with Rag Weed Allergy get sustained releif.

Recs

0
Member Avatar moscabo (20.85) Submitted: 11/17/2006 11:06:39 AM : Outperform Start Price: $7.60 DVAX Score: -67.63

Bear Stearns upgraded to outperform 11/17

Recs

0
Member Avatar baronvonlong (< 20) Submitted: 10/23/2006 6:02:49 PM : Outperform Start Price: $6.20 DVAX Score: -65.15

alot of good things in their pipeline

Recs

0
Member Avatar bpub (42.62) Submitted: 10/16/2006 4:28:32 PM : Outperform Start Price: $7.10 DVAX Score: -68.40

Heavy insider trading.

Recs

0
Member Avatar bikdout (22.93) Submitted: 10/12/2006 1:45:38 PM : Outperform Start Price: $6.62 DVAX Score: -67.14

This small cap stock has just broken out with experimantal studies showing their new product does effectively relieve ragweed allergies.

Recs

0
Member Avatar Inv4Peter (38.54) Submitted: 10/11/2006 12:12:18 PM : Outperform Start Price: $6.86 DVAX Score: -68.83

New product hype will die down in a few weeks.

Recs

0
Member Avatar b5l8 (< 20) Submitted: 10/6/2006 5:37:50 PM : Outperform Start Price: $7.29 DVAX Score: -69.83

MY on3 D4y PrED1c+10n on +Hi5 5+OcK 1$ +7%;-)

Recs

0
Member Avatar napainvestor (< 20) Submitted: 10/5/2006 1:34:46 PM : Outperform Start Price: $6.18 DVAX Score: -66.57

I think that this company is a great 'take-over' candidate.

Results 1 - 16 of 16

Featured Broker Partners